Comparison of marginal bone loss in platform switched and normal abutments with periimplant crevicular fluid biomarkers

Phase 1

Completed

• Conditions: preventive or screening interventions; biomarkers; peri-implant bone resorption; osteoclastogenesis

• Registration Number: TCTR20210721008
• Lead Sponsor: Istanbul University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-04-15
• Study Start: 2021-07-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

Healty patients in need of at least two implants in the posterior region, sites without acute infection or bone defects, at least 7 mm width of available crestal bone for 3.8 or 4.3 mm implants at least 9 mm height of bone.

Exclusion Criteria

Patients with systemic medical conditions, such as diabetes, and/or taking any medication(s) that could influence soft and hard tissue healing mechanisms.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bone loss 12 months Dental radiography,Biomarker analysis 1 and 12 months ELISA

Secondary Outcome Measures

Name	Time	Method
Gender distribution 12 months Data analysis